Corvus Pharmaceuticals, Inc.

10-K Item 1C cybersecurity disclosure describing the registrant's cybersecurity risk management program, governance structure (Audit Committee oversight), and CFO's responsibility for cybersecurity risk management. The filing explicitly states no known cybersecurity threats or prior incidents have materially affected or are reasonably likely to materially affect the company. No breach incident is disclosed.